Bone tissue engineering with porous hydroxyapatite ceramics

被引：317

作者：

Yoshikawa H. ^{[1
]}

Myoui A. ^{[1
]}

机构：

[1] Department of Orthopaedics, Osaka University, Graduate School of Medicine, Suita 565-0871

来源：

Journal of Artificial Organs | 2005年 / 8卷 / 3期

关键词：

Bone; Hydroxyapatite ceramics; Mesenchymal cell; Tissue engineering;

D O I：

10.1007/s10047-005-0292-1

中图分类号：

学科分类号：

摘要：

The main principle of bone tissue engineering strategy is to use an osteoconductive porous scaffold in combination with osteoinductive molecules or osteogenic cells. The requirements for a scaffold in bone regeneration are: (1) biocompatibility, (2) osteoconductivity, (3) interconnected porous structure, (4) appropriate mechanical strength, and (5) biodegradability. We recently developed a fully interconnected porous hydroxyapatite (IP-CHA) by adopting the "form-gel" technique. IP-CHA has a three-dimensional structure with spherical pores of uniform size that are interconnected by window-like holes; the material also demonstrated adequate compression strength. In animal experiments, IP-CHA showed superior osteoconduction, with the majority of pores filled with newly formed bone. The interconnected porous structure facilitates bone tissue engineering by allowing the introduction of bone cells, osteotropic agents, or vasculature into the pores. In this article, we review the accumulated data on bone tissue engineering using the novel scaffold, focusing especially on new techniques in combination with bone morphogenetic protein (BMP) or mesenchymal stem cells. © The Japanese Society for Artificial Organs 2005.

引用

页码：131 / 136

页数：5

共 35 条

[1]

Prolo D.J., Rodrigo J.J., Contemporary bone graft physiology and surgery, Clin Orthop, 200, pp. 322-342, (1985)

[2]

Arrington E.D., Smith W.J., Chambers H.G., Bucknell A.L., Davino N.A., Complications of iliac crest bone graft harvesting, Clin Orthop, 329, pp. 300-309, (1996)

[3]

Banwart J.C., Asher M.A., Hassanein R.S., Iliac crest bone graft harvest donor site morbidity. a statistical evaluation, Spine, 20, pp. 1055-1060, (1995)

[4]

Younger E.M., Chapman M.W., Morbidity at bone graft donor sites, J Orthop Trauma, 3, pp. 192-195, (1989)

[5]

Bucholz R.W., Carlton A., Holmes R.E., Hydroxyapatite and tricalcium phosphate bone graft substitute, Orthop Clin North Am, 18, pp. 323-334, (1987)

[6]

Ishihara K., Arai H., Nakabayashi N., Morita S., Furuya K.I., Adhesive bone cement containing hydroxyapatite particles as bone compatible filter, J Biomed Mater Res, 26, pp. 937-945, (1992)

[7]

Sartoris D.J., Gershuni D.H., Akeson W.H., Holmes R.E., Resnick D., Coralline hydroxyapatite bone graft substitutes: Preliminary report of radiographic evaluation, Radiology, 159, pp. 133-137, (1986)

[8]

Fujibayashi S., Kim H.M., Neo M., Uchida M., Kokubo T., Nakamura T., Repair of segmental long bone defect in rabbit femur using bioactive titanium cylindrical mesh cage, Biomaterials, 24, pp. 3445-3451, (2003)

[9]

Cornell C.N., Lane J.M., Chapman M., Merkow R., Seligson D., Henry S., Gustilo R., Vincent K., Multicenter trial of Collagraft as bone graft substitute, J Orthop Trauma, 5, pp. 1-8, (1991)

[10]

Holmes R.E., Bucholz R.W., Mooney V., Porous hydroxyapatite as a bone graft substitute in diaphyseal defects: A histometric study, J Orthop Res, 5, pp. 114-121, (1987)

← 1 2 3 4 →